Biopharmaceutical firm Cubist Pharmaceuticals is voluntarily recalling four lots of Cubicin (daptomycin for injection) 500mg in 50ml single use vials in the US primarily due to presence of glass particulates. The company said that no ...
Tags: Cubicin Injection, Cubist
The US Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables. The third BD Simplist product to be introduced includes Ondansetron ...
Therapeutic antibodies developer AnaptysBio has expanded its proprietary immunotherapy antibody portfolio to add multiple new combination therapies. The company developed a proprietary anti-PD-1 antibody, called ANB011, with key ...
Tags: AnaptysBio, Antibody Portfolio
Octapharma USA, part of Swiss human protein products maker Octapharma Group, has announced the availability of Octaplas, a solvent/detergent treated pooled human plasma, in the country. Designed to reduce the risk of pathogen transmission ...
Tags: protein products, Octapharma
US-based specialty pharmaceutical firm Upsher-Smith Laboratories will launch the generic version of its Morphine Sulfate extended-release (ER) capsules, CII on 4 September 2013. Morphine Sulfate ER Capsules, CII are currently available in ...
Tags: ER Capsules, pharmaceutical
Xi'an Janssen Pharmaceutical Ltd., the biggest subsidiary of US healthcare giant Johnson & Johnson in the Chinese mainland, is expected to see days be harder in the future. It was established by Janssen-Cilag, a subsidiary of Jonson & ...
Advanced Bionics has obtained the US Food and Drug Administration (FDA) approval for its new Naída CI Q70 (Naída CI) sound processor which is now commercially available in the US. Advanced Bionics in collaboration with ...
Tags: Advanced Bionics, Sound Processor
Fresenius Kabi USA has announced the availability of Levofloxacin in 5% dextrose injection in freeflex containers. Freeflex is a PVC-free, plasticizer-free, non-DEHP container, which is designed for easy handling and infusing the ...
Tags: Fresenius Kabi, Freeflex Container
SpineGuard has received 510(k) clearance from the US Food and Drug Administration (FDA) for three new products, designed to enhance pedicle screw penetration of small and/or difficult-to-access pedicles. The two miniaturized versions of ...
Tags: Pediguard Products, SpineGuard
The California State Assembly has passed a bill that restricts generic versions of medicines called biosimilars, upon their launch in the US. Biosimilars are medicines whose active drug substance is derived from living cells. They have ...
Tags: Biosimilar Drugs Bill, Medicine
Celator Pharmaceuticals, a pharmaceutical company developing therapies to treat cancer, has received US patent titled, ‘Lipid Carrier Compositions with Enhanced Blood Stability’ from the US Patent and Trademark Office on 27 ...
Clinical-stage biopharmaceutical company Pharmacyclics' new drug application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, has been accepted by the US FDA for two B-cell malignancy indications. ...
Tags: Solvay Group, Medicine
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use. Post transaction, which ...
Tags: Peptisyntha, Solvay Group
Clinical data services provider Discus Analytics has received a US patent for its JointMan software application from the US Patent Office. The company's flagship product, JointMan supports best practices in rheumatologic care, diagnosis ...
Tags: US Patent, Software Application
Belgium-based pharmaceutical contract manufacturer Sanico has installed four Insight PH metal detectors from Lock Inspection Systems at its Turnhout facility in Belgium, to boost tablet inspection capability with 100% accuracy. The drug ...